News Focus
News Focus
icon url

Lady-baron

10/24/13 7:03 AM

#280475 RE: AugustaFriends #280470

VICL for sure :-)
What particular interests me is the fact that they will provide details on independent and partnered development programs in the conference call and webcast.
Could this be about the AnGes news that someone posted here yesterday... hmmmm

Or the multinational Phase 3 registration trial of ASP0113 which was initiated in June 2013 and is expected to enroll approximately 500 hematopoietic cell transplant (HCT) recipients. Astellas is conducting the trial, and Vical is providing development, regulatory and manufacturing support. Astellas expects to begin a separate Phase 2 trial of ASP0113 in solid organ transplant (SOT) recipients later this year.
icon url

Newsguy1

10/24/13 7:21 AM

#280478 RE: AugustaFriends #280470

VICL they sound pretty confident this morning( but don't they all) about the ER. I see a steady climb until then.
icon url

jimbob4stocks

10/24/13 7:32 AM

#280482 RE: AugustaFriends #280470

VICL runner!
icon url

jimbob4stocks

10/24/13 8:17 AM

#280490 RE: AugustaFriends #280470

Would be great to see it open up over 1.53
icon url

ChipTFM

10/24/13 9:51 AM

#280510 RE: AugustaFriends #280470

VICL some selling on news.